HOME >> BIOLOGY >> NEWS
Two molecules work together to aid transport of immune cells, UT Southwestern researchers find

DALLAS April 20, 2004 New research findings about T-cell transport shed light on how the normal immune system functions and could have implications in fighting autoimmune and inflammatory diseases, say researchers at UT Southwestern Medical Center at Dallas.

Two molecules on the surfaces of T-cells a type of immune cell must work in tandem to help the T-cells cross from the bloodstream into infected tissues, where the T-cells initiate an immune or inflammatory response, researchers at UT Southwestern have discovered.

The research, which was done in mice, appears in the April 21 issue of the journal Immunity.

In order to fight certain infections, T-cells must migrate from the bloodstream and into infected tissue. T-cells also cross blood vessel walls to initiate inflammatory or autoimmune responses in diseases such as rheumatoid arthritis, type 1 diabetes, lupus, asthma, Crohn's disease and colitis.

Scientists know that two specific molecules, or receptors, on passing T-cells in the bloodstream interact with receptors on the walls of blood vessels. One T-cell receptor, called CD44, is responsible for getting the T-cells to "roll" along the blood vessel wall.

"CD44 governs the rolling behavior of the T-cell, where it touches and then lifts off the vascular wall," said Dr. Mark Siegelman, associate professor of pathology at UT Southwestern and senior author of the study.

A second receptor, VLA-4, stops the T-cells from rolling. This step in the process is called firm adhesion.

"You need both of these steps in order to get the T-cells out of the blood vessel and into tissue," Dr. Siegelman said. "Only by completing the second step, firm adhesion, has the T-cell committed to sticking and getting out."

In the new research, UT Southwestern scientists found that in order to get the T-cells to stick firmly to the vascular wall, the CD44 and VLA-4 receptors on the T-cell had to be physically linked. If they
'"/>

Contact: Amanda Siegfried
Amanda.siegfried@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
20-Apr-2004


Page: 1 2

Related biology news :

1. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
2. Synthesized molecules studied as weapon to stop cell division in cancer cells
3. Scientists reinvent DNA as template to produce organic molecules
4. Sweet success in targeting sugar molecules to cells in living animals
5. UC Riverside researcher takes snapshots of the movement of molecules in a billionth of a second
6. Scientists pinpoint molecules that generate synapses
7. Controlling biomolecules with magnetic tweezers
8. Water molecules clump more loosely than previously thought
9. Creating polymers that act like biomolecules
10. A new way to see DNA (and other tiny molecules)
11. St. Jude shows how disorderliness in some proteins lets them interact with a diversity of molecules

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2019)... ... September 25, 2019 , ... LeadingBiotech ... and dialogue, today announces its inaugural South CEO conference to be ... , Co-produced by Tulane University, this invitation-only meeting convenes biopharma executives to ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... interactions for accelerated drug development, announced today that it has raised $2.8M from ... OS Fund and also includes AME Cloud Ventures, Boom Capital, Madrona Venture Group, ...
(Date:9/17/2019)... ... September 17, 2019 , ... Last week, Blackrock Microsystems, ... from the Medical University of Warsaw, met at the Presidential Palace of the ... a neuroprosthetic system as part of an initiative called "Startups in the Palace ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has ... October 18-19th, 2019 in Las Vegas with spots still open. , The speaker, Dr. ... several Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as the ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell biotechnology company Asymmetrex ... Like the company’s precursor patent, approved in the U.S. in 2017, the new patent ... Asymmetrex now markets the technology in the U.S. as the AlphaSTEM Test™. ...
(Date:10/3/2019)... Calif. (PRWEB) , ... October 02, 2019 , ... ... business opportunity to investors and venture capital companies in Silicon Valley at a special ... 8:30 pm. The event will be held at the JJ Lake Business Center located ...
(Date:9/30/2019)... ... September 30, 2019 , ... The September ... Rigaku Corporation , is now available online on the company’s global website. The ... including X-ray diffraction, fluorescence and imaging, and presents articles, scientific papers and news ...
Breaking Biology Technology:
Cached News: